| CAT # | Izina ryibicuruzwa | Ibisobanuro |
| CPD0004 | Ertugliflozin | E. |
| CPDA0048 | Omarigliptin | Omarigliptin, izwi kandi ku izina rya MK-3102, ni imbaraga zikomeye kandi zimara igihe kirekire DPP-4 inhibitori yo kuvura rimwe mu cyumweru kuvura diyabete yo mu bwoko bwa 2. |
| CPDA1089 | Retagliptin | Retagliptin, izwi kandi ku izina rya SP-2086, ni DPP-4 inhibitor ishobora gukoreshwa mu kuvura diyabete yo mu bwoko bwa 2. |
| CPDA0088 | Trelagliptin | Trelagliptin, izwi kandi ku izina rya SYR-472, ni inzitizi ndende ya dipeptidyl peptidase-4 (DPP-4) inhibitor ikorwa na Takeda mu rwego rwo kuvura diyabete yo mu bwoko bwa 2 (T2D). |
| CPDA2039 | Linagliptin | Linagliptin, izwi kandi ku izina rya BI-1356, ni inhibitor ya DPP-4 yakozwe na Boehringer Ingelheim mu kuvura diyabete yo mu bwoko bwa II. |
| CPDA0100 | Sitagliptin | Sitagliptin (INN; mbere yiswe MK-0431 ikagurishwa ku izina ry'ubucuruzi Januvia) ni imiti igabanya ubukana bwo mu kanwa (imiti irwanya diyabete) yo mu cyiciro cya inhibitori ya dipeptidyl peptidase-4 (DPP-4). |
| CPD0854 | LX-4211 | LX-4211 nimbaraga ebyiri SGLT2 / 1 inhibitor; Imiti igabanya ubukana. |
| CPDA1553 | LX-2761 | LX2761 ni inhibitor ya SGLT1 ikora cyane muri vitro kandi ikadindiza kwinjiza amara glucose muri vivo kugirango irusheho kurwanya glycemic. |
